Off-label indications for atypical antipsychotics: A systematic review

  title={Off-label indications for atypical antipsychotics: A systematic review},
  author={Konstantinos N Fountoulakis and Ioannis Nimatoudis and Apostolos Iacovides and George S. Kaprinis},
  journal={Annals of General Hospital Psychiatry},
  pages={4 - 4}
INTRODUCTION: With the introduction of newer atypical antipsychotic agents, a question emerged, concerning their use as complementary pharmacotherapy or even as monotherapy in mental disorders other than psychosis. MATERIAL AND METHOD: MEDLINE was searched with the combination of each one of the key words: risperidone, olanzapine and quetiapine with key words that refered to every DSM-IV diagnosis other than schizophrenia and other psychotic disorders, bipolar disorder and dementia and memory… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 13 extracted citations

Review of atypical antipsychotics in anxiety.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology • 2011
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 123 references

A novel augmentation strategy for treating resistant major depression.

The American journal of psychiatry • 2001
View 6 Excerpts
Highly Influenced

Melman CT: A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities

JK Buitelaar, RJ van der Gaag, P Cohen-Kettenis
J Clin Psychiatry • 2001
View 5 Excerpts
Highly Influenced

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study.

International clinical psychopharmacology • 2001
View 6 Excerpts
Highly Influenced

Quetiapine resolves psychotic depression in an adolescent boy.

Journal of child and adolescent psychopharmacology • 2001
View 10 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…